Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.520
+0.030 (2.01%)
At close: Apr 2, 2026, 4:00 PM EDT
1.538
+0.018 (1.17%)
After-hours: Apr 2, 2026, 7:58 PM EDT
Neuronetics Employees
Neuronetics had 658 employees as of December 31, 2025. The number of employees decreased by 58 or -8.10% compared to the previous year.
Employees
658
Change (1Y)
-58
Growth (1Y)
-8.10%
Revenue / Employee
$226,682
Profits / Employee
-$59,267
Market Cap
105.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 658 | -58 | -8.10% |
| Dec 31, 2024 | 716 | 513 | 252.71% |
| Sep 30, 2024 | 201 | -10 | -4.74% |
| Jun 30, 2024 | 203 | -6 | -2.87% |
| Mar 31, 2024 | 202 | 2 | 1.00% |
| Dec 31, 2023 | 203 | 9 | 4.64% |
| Sep 30, 2023 | 211 | 13 | 6.57% |
| Jun 30, 2023 | 209 | 25 | 13.59% |
| Mar 31, 2023 | 200 | 13 | 6.95% |
| Dec 31, 2022 | 194 | 19 | 10.86% |
| Sep 30, 2022 | 198 | 33 | 20.00% |
| Jun 30, 2022 | 184 | 23 | 14.29% |
| Mar 31, 2022 | 187 | 40 | 27.21% |
| Dec 31, 2021 | 175 | 49 | 38.89% |
| Sep 30, 2021 | 165 | 43 | 35.25% |
| Jun 30, 2021 | 161 | 47 | 41.23% |
| Mar 31, 2021 | 147 | 30 | 25.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Treace Medical Concepts | 450 |
| Xtant Medical Holdings | 232 |
| AVITA Medical | 226 |
| Rapid Micro Biosystems | 171 |
| Baird Medical Investment Holdings | 143 |
| InspireMD | 127 |
| Hyperfine | 102 |
| MaxCyte | 91 |
STIM News
- 17 days ago - Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 17 days ago - Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer - GlobeNewsWire
- 7 weeks ago - Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 months ago - Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga
- 5 months ago - TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression - GlobeNewsWire
- 5 months ago - Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript - Seeking Alpha